Pregled bibliografske jedinice broj: 494520
VACCINE PROPERTIES OF RECOMBINANT HERPESVIRUS EXPRESSING LIGAND FOR NKG2D RECEPTOR
VACCINE PROPERTIES OF RECOMBINANT HERPESVIRUS EXPRESSING LIGAND FOR NKG2D RECEPTOR // Annual Meeting of the Austrian Society for Allergology and Immunology 2010
Beč, Austrija, 2010. (pozvano predavanje, međunarodna recenzija, pp prezentacija, ostalo)
CROSBI ID: 494520 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
VACCINE PROPERTIES OF RECOMBINANT HERPESVIRUS EXPRESSING LIGAND FOR NKG2D RECEPTOR
Autori
Stipan Jonjić
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, pp prezentacija, ostalo
Skup
Annual Meeting of the Austrian Society for Allergology and Immunology 2010
Mjesto i datum
Beč, Austrija, 03.12.2010. - 05.12.2010
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
VACCINE PROPERTIES; NKG2D; RECOMBINANT HERPESVIRUS
Sažetak
Human CMV (HCMV) is a major cause of morbidity and mortality in both congenitally infected and immunocompromised individuals. Development of an effective HCMV vaccine would help protect these vulnerable groups. NK group 2, member D (NKG2D) is a potent activating receptor expressed by cells of the innate and adaptive immune systems. Its importance in HCMV immune surveillance is indicated by the elaborative evasion mechanisms evolved by the virus to avoid NKG2D. In order to study this signaling pathway, we engineered a recombinant mouse CMV expressing the high-affinity NKG2D ligand RAE-1γ (RAE-1γMCMV). Expression of RAE-1γ by MCMV resulted in profound virus attenuation in vivo and lower latent viral DNA loads. RAE-1γMCMV infection was efficiently controlled by immunodeficient hosts, including mice lacking type I interferon receptors or immunosuppressed by sublethal γ-irradiation. Features of MCMV infection in neonates were also diminished. Despite tight innate immune control, RAE-1γMCMV infection elicited strong and long-lasting protective immunity. Maternal RAE-1γMCMV immunization protected neonatal mice from MCMV disease via placental transfer of antiviral Abs. Despite strong selective pressure, the RAE-1γ transgene did not exhibit sequence variation following infection. Together, our results indicate that use of a recombinant virus encoding the ligand for an activating NK cell receptor could be a powerful approach to developing a safe and immunogenic HCMV vaccine.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
062-0621261-1263 - Molekularni mehanizmi citomegalovirusnog izmicanja imunološkom nadzoru (Jonjić, Stipan, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Stipan Jonjić
(autor)